Davis Gregory D 4
4 · SANGAMO THERAPEUTICS, INC · Filed May 27, 2026
Research Summary
AI-generated summary of this filing
Sangamo (SGMO) Head of Research Gregory D. Davis Sells 1,630 Shares
What Happened Gregory D. Davis, Head of Research & Technology at Sangamo Therapeutics (SGMO), had a portion of his RSU award vest on May 25, 2026 and surrendered 1,630 shares to the company to satisfy mandatory tax withholding. The filing reports the disposition at $0.17/share for a total of $284; the issuer's closing price used for withholding was $0.1743/share.
Key Details
- Transaction date: May 25, 2026; Form 4 filed May 27, 2026 (appears timely).
- Disposition: 1,630 shares surrendered for tax withholding; reported price $0.17/share (issuer closing price used for withholding: $0.1743/share); total ~$284.
- Vesting detail: 3,031 shares vested on May 25, 2026; 1,630 of those were surrendered for taxes, leaving 1,401 vested shares delivered to the reporting person from this installment.
- Future vesting: An additional 32,633 shares from the February 25, 2025 RSU grant remain and will vest in seven equal quarterly installments, subject to continued service and plan terms (per footnote).
- Footnote nature: This was a mandatory tax-withholding disposition (code F) and not an open-market sale or discretionary trade.
Context This was a routine tax-withholding transaction tied to RSU vesting, not a market sale intended to realize gains. Such withholding dispositions are common when equity awards vest and generally do not signal insider sentiment about the company's prospects.
Insider Transaction Report
Form 4
Davis Gregory D
Head of Research & Technology
Transactions
- Tax Payment
Common Stock
[F1][F2]2026-05-25$0.17/sh−1,630$284→ 113,654 total
Footnotes (2)
- [F1]Represents shares underlying the portion of an RSU grant that vested on May 25, 2026, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on May 25, 2026 of $0.1743/share, pursuant to the terms of the 2018 EIP. This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise.
- [F2]Includes: 3,031 shares from the May 25, 2026 vesting installment of the Reporting Person's February 25, 2025 RSU grant and the remaining 32,633 shares will vest in 7 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
Signature
/s/ Scott Willoughby, Attorney-in-Fact|2026-05-27